Literature DB >> 16441692

Biocompatible properties of surgical mesh using an animal model.

Hannah G Krause1, Stuart J Galloway, Soo K Khoo, Richard Lourie, Judith T W Goh.   

Abstract

AIM: To study the biocompatibility of surgical meshes for use in pelvic reconstructive surgery using an animal model.
METHODS: Eight different types of mesh: Atrium, Dexon, Gynemesh, IVS tape, Prolene, SPARC tape, TVT tape and Vypro II, were implanted into the abdominal walls of rats for 3 months' duration. Explanted meshes were assessed, using light microscopy, for parameters of rejection and incorporation.
RESULTS: Type 1 (Atrium, Gynemesh, Prolene, SPARC and TVT) and type 3 (Vypro II, Dexon and IVS) meshes demonstrated different biocompatible properties. Inflammatory cellular response and fibrosis at the interface of mesh and host tissue was most marked with Vypro II and IVS. All type 1 meshes displayed similar cellular responses despite markedly different mesh architecture.
CONCLUSIONS: The inflammatory response and fibrous reaction in the non-absorbable type 3 meshes tested (IVS and Vypro II) was more marked than the type 1 meshes. The increased inflammatory and fibrotic response may be because of the multifilamentous polypropylene components of these meshes. Material and filament composition of mesh is the main factor in determining cellular response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441692     DOI: 10.1111/j.1479-828X.2006.00513.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  17 in total

1.  Late urethral erosion of transobturator suburethral mesh (Obtape): a minimally invasive management under local anaesthesia.

Authors:  Tiago Moura Mendonça; David Martinho; José Palma Dos Reis
Journal:  Int Urogynecol J       Date:  2010-08-04       Impact factor: 2.894

Review 2.  The use of synthetic sub-urethral slings in the treatment of female stress urinary incontinence.

Authors:  Andrew Feifer; Jacques Corcos
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-04-27

Review 3.  Surgical mesh for ventral incisional hernia repairs: Understanding mesh design.

Authors:  Ali Rastegarpour; Michael Cheung; Madhurima Vardhan; Mohamed M Ibrahim; Charles E Butler; Howard Levinson
Journal:  Plast Surg (Oakv)       Date:  2016       Impact factor: 0.947

Review 4.  Polypropylene mesh and the host response.

Authors:  Hiren Patel; Donald R Ostergard; Gina Sternschuss
Journal:  Int Urogynecol J       Date:  2012-03-20       Impact factor: 2.894

5.  Animal models of female pelvic organ prolapse: lessons learned.

Authors:  Bruna M Couri; Andrew T Lenis; Ali Borazjani; Marie Fidela R Paraiso; Margot S Damaser
Journal:  Expert Rev Obstet Gynecol       Date:  2012-05-01

6.  Tissue response to a new type of biomaterial implanted subcutaneously in rats.

Authors:  Marie Boennelycke; Lise Christensen; Lene Feldskov Nielsen; Hanne Everland; Gunnar Lose
Journal:  Int Urogynecol J       Date:  2010-09-14       Impact factor: 2.894

7.  Functional skeletal muscle formation with a biologic scaffold.

Authors:  Jolene E Valentin; Neill J Turner; Thomas W Gilbert; Stephen F Badylak
Journal:  Biomaterials       Date:  2010-07-17       Impact factor: 12.479

8.  Tissue reaction to urogynecologic meshes: effect of steroid soaking in two different mesh models.

Authors:  Aysun Karabulut; Serap Aynur Simavlı; Gülçin Mete Abban; Şahika Pınar Akyer; Nazan Keskin; Semih Tan; Barbaros Şahin
Journal:  Int Urogynecol J       Date:  2016-04-02       Impact factor: 2.894

9.  Highly purified collagen coating enhances tissue adherence and integration properties of monofilament polypropylene meshes.

Authors:  Rodrigo Teixeira Siniscalchi; Marli Melo; Paulo César Rodrigues Palma; Inácio Maria Dal Fabbro; Benedicto de Campos Vidal; Cassio Luiz Zanettini Riccetto
Journal:  Int Urogynecol J       Date:  2013-05-04       Impact factor: 2.894

10.  Imaging findings of implanted absorbable mesh in patients with breast partial resection.

Authors:  Hyon Joo Kwag
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.